Wang Xiuyan, Xu Sicheng, Liu Guangming, Caikai Shareli
Department of Respiratory Intensive Care Unit (RICU), the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, Xinjiang, China. Corresponding author: Xu Sicheng, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 May;26(5):330-4. doi: 10.3760/cma.j.issn.2095-4352.2014.05.009.
To investigate the timing and value of noninvasive ventilation (NIV) as a weaning tool immediately after early extubation in patients with acute respiratory distress syndrome (ARDS).
A prospective randomized controlled trial was conducted. The ARDS patients with surgical diseases admitted to Department of Respiratory Intensive Care Unit (RICU) of the First Affiliated Hospital of Xinjiang Medical University were enrolled. The patients were randomly divided into sequential group and control group. All patients underwent endotracheal intubation and were mechanically ventilated. Every 12 hours during the first 3 days, the lung recruitment maneuver was performed during pressure control ventilation (PCV). After lung recruitment, all patients were ventilated with synchronized intermittent mandatory ventilation (SIMV) + pressure support ventilation (PSV) + positive end-expiratory pressure (PEEP) or assistant/control ventilation (A/C). The objects in sequential group who met the following criteria including those with oxygen index (PaO2/FiO2) reaching 200-250 mmHg (1 mmHg=0.133 kPa) under PEEP of 8 cmH2O (1 cmH2O=0.098 kPa), and pressure support of 12 cmH2O, and most acute infiltrating lesions having resolved on chest imaging, received noninvasive ventilation (NIV) immediately after extubation, and patients in control group continued to have invasive mechanical ventilation via intubation or tracheostomy with an endotracheal tube. The baseline data in both groups and the number of re-intubation in the sequential group were recorded. The duration of invasive mechanical ventilation and total duration of mechanical ventilation, ICU length of stay, the incidence of ventilator-associated pneumonia (VAP), and mortality rate were compared between the two groups.
53 consecutive adult patients were enrolled, including 26 in sequential group and 27 cases in control group. The period of endotracheal intubation was 7.0 (6.8, 9.5) days, and 7.7% (2/26) patients underwent re-intubation in sequential group. There were significant difference in respiratory and circulatory indicators before extubation spontaneous breathing trial (SBT) ≤10 minutes in sequential group, indicating that the patients were still in the early stage of extubation sequential NIV. There was no significant difference in indices reflecting respiratory function and circulation between the two groups, except that respiratory rate at 1 hour was slightly increased in sequential group as compared with that of control group, indicating that sequential NIV could maintain invasive ventilation function. There was significant difference in duration of invasive mechanical ventilation [7.0 (6.8, 9.5) days vs. 21.0 (17.0, 25.0) days, Z=-6.048, P=0.000], duration of total mechanical ventilation (18.0±4.1 days vs. 22.0±7.3 days, t=-2.805, P=0.008), and length of ICU stay (21.0±4.1 days vs. 28.0±8.1 days, t=-4.012, P=0.000) between sequential group and control group, but there was no significant differences in the incidence of VAP [15.4% (4/26) vs. 29.6 (8/27), χ(2)=1.535, P=0.215] and mortality rate [7.7% (2/26) vs. 18.5% (5/27), P=0.420].
When PaO2/FiO2 reached 200-250 mmHg under the condition of low ventilation, sequential NIV facilitates the early discontinuation of mechanical ventilation in ARDS patients with surgical diseases, with shortening of duration of invasive mechanical ventilation, total mechanical ventilation, and the length of ICU stay.
探讨无创通气(NIV)作为急性呼吸窘迫综合征(ARDS)患者早期拔管后立即撤机工具的时机和价值。
进行一项前瞻性随机对照试验。纳入新疆医科大学第一附属医院呼吸重症监护病房(RICU)收治的患有外科疾病的ARDS患者。将患者随机分为序贯组和对照组。所有患者均行气管插管并接受机械通气。在最初3天内,每12小时在压力控制通气(PCV)期间进行肺复张手法。肺复张后,所有患者均采用同步间歇指令通气(SIMV)+压力支持通气(PSV)+呼气末正压(PEEP)或辅助/控制通气(A/C)进行通气。序贯组中符合以下标准的患者,包括在8 cmH2O(1 cmH2O = 0.098 kPa)的PEEP、12 cmH2O的压力支持下氧合指数(PaO2/FiO2)达到200 - 250 mmHg(1 mmHg = 0.133 kPa),且胸部影像学上大多数急性浸润性病变已消退,在拔管后立即接受无创通气(NIV),而对照组患者继续通过气管插管或气管切开进行有创机械通气。记录两组的基线数据以及序贯组再次插管的次数。比较两组患者有创机械通气时间、机械通气总时长、ICU住院时间、呼吸机相关性肺炎(VAP)发生率及死亡率。
连续纳入53例成年患者,其中序贯组26例,对照组27例。气管插管时间为7.0(6.8,9.5)天,序贯组有7.7%(2/26)的患者接受了再次插管。序贯组在拔管自主呼吸试验(SBT)≤10分钟前呼吸和循环指标存在显著差异,表明患者仍处于序贯NIV拔管的早期阶段。两组间反映呼吸功能和循环的指标无显著差异,除序贯组1小时呼吸频率较对照组略有增加外,表明序贯NIV可维持有创通气功能。序贯组和对照组在有创机械通气时间[7.0(6.8,9.5)天 vs. 21.0(17.0,25.0)天,Z = -6.048,P = 0.000]、机械通气总时长(18.0±4.1天 vs. 22.0±7.3天,t = -2.805,P = 0.008)及ICU住院时间(21.0±4.1天 vs. 28.0±8.1天,t = -4.012,P = 0.000)方面存在显著差异,但在VAP发生率[15.4%(4/26) vs. 29.6%(8/27),χ² = 1.535,P = 0.215]和死亡率[7.7%(2/26) vs. 18.5%(5/27),P = 0.420]方面无显著差异。
在低通气条件下当PaO2/FiO2达到200 - 250 mmHg时,序贯NIV有助于患有外科疾病的ARDS患者早期停用机械通气,缩短有创机械通气时间、机械通气总时长及ICU住院时间。